CareDx, Inc. (CDNA): Total Liabilities
$110.13M
As of 2025-12-31
$107.39M
As of 2026-06-30
-0.6%
3-year compound annual growth
+3.9%
5-year compound annual growth
+15.5%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $110.13M | -2.2% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $112.62M | -45.2% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $205.50M | +83.3% | 2025-02-28, Balance as of period end |
| 2022-12-31 | $112.08M | +11.3% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $100.75M | +10.9% | 2023-02-27, Balance as of period end |
| 2020-12-31 | $90.83M | +72.2% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $52.74M | +51.7% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $34.77M | -61.2% | 2020-02-28, Balance as of period end |
| 2017-12-31 | $89.52M | +57.1% | 2019-03-06, Balance as of period end |
| 2016-12-31 | $56.97M | +117.9% | 2018-03-22, Balance as of period end |
| 2015-12-31 | $26.14M | +31.8% | 2017-04-21, Balance as of period end |
| 2014-12-31 | $19.84M | -21.7% | 2016-03-29, Balance as of period end |
| 2013-12-31 | $25.34M | n/a | 2015-03-31, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| CareDx, Inc. (CDNA) | 2025-12-31 | $110.13M | -2.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $107.68M | +42.8% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $106.81M | +17.6% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $152.55M | +13.6% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $96.44M | -22.3% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $548.36M | -11.7% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $344.15M | -28.3% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.11B | +30.0% |
| Biodesix Inc (BDSX) | 2025-12-31 | $89.94M | +17.8% |
Compare CDNA, CSTL, FLGT, BLLN side by side · Screen every company in Services-Medical Laboratories ↗